DK201590D0 - Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse - Google Patents

Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse

Info

Publication number
DK201590D0
DK201590D0 DK201590A DK201590A DK201590D0 DK 201590 D0 DK201590 D0 DK 201590D0 DK 201590 A DK201590 A DK 201590A DK 201590 A DK201590 A DK 201590A DK 201590 D0 DK201590 D0 DK 201590D0
Authority
DK
Denmark
Prior art keywords
milk
hyperimmun
hypertensive
preparation
composition
Prior art date
Application number
DK201590A
Other languages
Danish (da)
English (en)
Other versions
DK201590A (da
Inventor
Lee R Beck
Ralph J Stolle
Original Assignee
Stolle Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stolle Res & Dev filed Critical Stolle Res & Dev
Publication of DK201590D0 publication Critical patent/DK201590D0/da
Publication of DK201590A publication Critical patent/DK201590A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18—Treatment of tobacco products or tobacco substitutes
    • A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK201590A 1988-02-26 1990-08-22 Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse DK201590A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/161,039 US4879110A (en) 1983-10-27 1988-02-26 Antihypertensive hyperimmune milk, production, composition, and use
PCT/US1989/000718 WO1989007948A1 (en) 1988-02-26 1989-02-23 Antihypertensive hyperimmune milk, production, composition, and use

Publications (2)

Publication Number Publication Date
DK201590D0 true DK201590D0 (da) 1990-08-22
DK201590A DK201590A (da) 1990-08-22

Family

ID=22579548

Family Applications (1)

Application Number Title Priority Date Filing Date
DK201590A DK201590A (da) 1988-02-26 1990-08-22 Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse

Country Status (15)

Country Link
US (1) US4879110A (es)
EP (1) EP0330521B1 (es)
JP (1) JP2792973B2 (es)
AT (1) ATE88349T1 (es)
AU (1) AU621604B2 (es)
CA (1) CA1339760C (es)
DE (1) DE68906054T2 (es)
DK (1) DK201590A (es)
ES (1) ES2039847T3 (es)
HK (1) HK1005013A1 (es)
IE (1) IE63032B1 (es)
IL (1) IL89352A (es)
MX (1) MX168997B (es)
NZ (1) NZ228105A (es)
WO (1) WO1989007948A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352462A (en) * 1982-06-03 1994-10-04 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US5194255A (en) * 1982-06-03 1993-03-16 Stolle Research & Development Corporation Antihypertensive hyperimmune milk, production, composition, and use
US5863561A (en) * 1982-06-03 1999-01-26 Stolle Research & Development Corporation Immune suppressive product
US6054124A (en) * 1982-06-03 2000-04-25 Stolle Milk Biologics, Inc. Immune suppressive product
US5106618A (en) * 1987-07-02 1992-04-21 Stolle Research And Development Corporation Method of treating protozoal gastrointestinal disorders by administering hyperimmune milk product
US4994496A (en) * 1987-09-09 1991-02-19 Repasky Elizabeth A Use of milk globules as carriers for drugs
US5128127A (en) * 1989-02-08 1992-07-07 Stolle Research & Development Corp. Increased protein production in animals
EP0646017A1 (en) * 1990-07-05 1995-04-05 The Stolle Research And Development Corporation Immune suppressive product
US6056978A (en) * 1992-06-16 2000-05-02 Stolle Milk Biologics, Inc. Use of hyperimmune milk to prevent suppression of T-lymphocyte production
JPH07507798A (ja) * 1992-06-16 1995-08-31 ストール・ミルク・バイオロジクス・インコーポレイテッド 寿命延長のための高度免疫乳の使用
WO2002040051A1 (en) * 2000-11-15 2002-05-23 Fonterra Co-Operative Group Limited Colostrum-based composition
US6770280B1 (en) 2001-11-15 2004-08-03 Humanetics Corporation Treatment of menorrhagia, hypermenorrhea, dysmenorrhea and menstrual migraines by the administration of an antibacterial milk product
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
US10478493B2 (en) 2015-08-31 2019-11-19 Stolle Milk Biologics, Inc. Method of treating protozoal gastrointestinal disorders in immunocompromised patients

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA587849A (en) * 1959-12-01 E. Petersen William Production of protective principle
US2175090A (en) * 1938-06-22 1939-10-03 Lederie Lab Inc Purification of antibody compositions
US3128230A (en) * 1961-04-04 1964-04-07 Sunbury Milk Products Co Milk having antibodies therein and process for producing same
US3376198A (en) * 1965-07-21 1968-04-02 Collins Products Inc Method of producing antibodies in milk
SE337183B (es) * 1967-04-28 1971-07-26 B Selander
GB1211876A (en) * 1967-11-23 1970-11-11 Twyford Lab Ltd Improvements in and relating to prophylactic and therapeutic preparations
US3911108A (en) * 1973-02-14 1975-10-07 Diamond Shamrock Corp Process of producing bovine milk products containing specific antibodies
CH590064A5 (es) * 1973-11-28 1977-07-29 Biokema Sa
CA1007568A (en) * 1973-12-13 1977-03-29 Michael C. Attwell Bovine immunoglobulin isolation process
US4324782A (en) * 1974-01-28 1982-04-13 Beck Lee R Dental caries inhibiting product of immunized cow's milk having antibodies specific to killed Streptococcus mutans cells
US3987161A (en) * 1974-06-19 1976-10-19 The Procter & Gamble Company Composition and method for conditioning hair with hair antiserum
CH625415A5 (en) * 1975-05-20 1981-09-30 Stolle Res & Dev Process for the production of milk with an anticaries action and use thereof for the production of a composition with an anticaries action
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
FR2452881A1 (fr) * 1979-04-04 1980-10-31 Bel Fromageries Procede de preparation de proteines animales ou vegetales, particulierement de lactoproteines, et nouveaux produits ainsi obtenus
US4284623A (en) * 1979-11-09 1981-08-18 Beck Lee R Method of treating inflammation using bovine milk
FR2487642B2 (fr) * 1980-07-31 1985-10-18 Bel Fromageries Procede de preparation de fractions proteiques par ultrafiltration et chromatographie d'exclusion et d'echange d'ions
EP0064103B1 (en) * 1981-04-28 1985-11-06 The Stolle Research And Development Corporation Method of obtaining an anti-inflammatory bovine milk
US4956349A (en) * 1983-10-27 1990-09-11 Stolle Research & Development Corporation Anti-inflammatory factor, method of isolation, and use
US4636384A (en) * 1982-06-03 1987-01-13 Stolle Research & Development Corporation Method for treating disorders of the vascular and pulmonary systems
BE901672A (fr) * 1985-02-07 1985-08-07 Oleofina Sa Procede de purification de proteines du lait et de ses derives.
US4684623A (en) * 1985-05-02 1987-08-04 The Board Of Trustees Of The Cetus Corporation Use of tumor necrosis factor as a weight regulator
EP0300102B1 (en) * 1987-07-21 1993-03-24 The Stolle Research And Development Corporation Improved method of obtaining immune regulatory factors by mammal immunization
SE458818B (sv) * 1987-11-27 1989-05-16 Svenska Mejeriernas Riksforeni Foerfarande foer utvinning av rena fraktioner av laktoperoxidas och laktoferrin ur mjoelkserum

Also Published As

Publication number Publication date
WO1989007948A1 (en) 1989-09-08
AU3350089A (en) 1989-09-22
IE890607L (en) 1989-08-26
DE68906054T2 (de) 1993-09-16
US4879110A (en) 1989-11-07
EP0330521A3 (en) 1990-10-31
IL89352A0 (en) 1989-09-10
AU621604B2 (en) 1992-03-19
ATE88349T1 (de) 1993-05-15
CA1339760C (en) 1998-03-17
IL89352A (en) 1994-06-24
EP0330521A2 (en) 1989-08-30
ES2039847T3 (es) 1993-10-01
MX168997B (es) 1993-06-16
IE63032B1 (en) 1995-03-22
EP0330521B1 (en) 1993-04-21
DK201590A (da) 1990-08-22
HK1005013A1 (en) 1998-12-18
JPH03505866A (ja) 1991-12-19
DE68906054D1 (de) 1993-05-27
JP2792973B2 (ja) 1998-09-03
NZ228105A (en) 1990-10-26

Similar Documents

Publication Publication Date Title
NO900533D0 (no) Forbindelse for smoeremiddelsammensetninger, smoeremiddelsammensetning-konsentrat og fremgangsmaate for fremstilling av sammensetningen.
ATE91139T1 (de) Waermestabilisierte copolymerzusammensetzung.
DK201590A (da) Antihypertensiv hyperimmun maelk, fremstilling, sammensaetning og anvendelse
DE3783069D1 (de) Kopolymerzusammensetzung.
ATE56968T1 (de) Substituierte oxo-piperazinyl-triazine und uvlicht stabilisierte zubereitungen.
DE3871751D1 (de) Gelbildende organosiloxanzusammensetzungen und deren verwendung.
DE3786236D1 (de) Aethylen-copolymerzusammensetzung.
DE3769458D1 (de) Physiologisch wirksame und naehrende zusammensetzung.
DE3689577D1 (de) Wärmebeständige Polyolefinzusammensetzung.
DE3875300D1 (de) Turbo-verbundmaschine.
DE3780209D1 (de) Dreh- und kipptisch.
DE3770604D1 (de) Imidverbindung und diese enthaltende zusammensetzung.
DE3579148D1 (de) Polypeptid und polypeptidzusammensetzung.
NO871053D0 (no) Anvendelse av substituerte n-triklormetyltiodikarboksimider i kombinasjon med n,n[-substituerte bis-(2,4-diamino-s-triazin-6-yl)-oligosulfider i vulkaniserbare kautsjukblandinger og slike kautsjukblandinger.
DE3789530D1 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
ES544787A0 (es) Preparaciones medicinales solidas
DE3671446D1 (de) 5-aralkylsubstituierte 2h-benztriazole und stabilisierte zusammensetzungen.
PT71983B (en) N-aryl-n'-imidazol-2-ylureas compositions and methods
DK164785C (da) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner, deres fremstilling og deres anvendelse til fremstilling af antipedressive midler
DE68917944D1 (de) O.R.I.-gehemmte Motorbrennstoffzusammensetzung, und einlagerungsbeständiges Konzentrat.
DE58909846D1 (de) Siliciumnitridpulver mit geringem Sauerstoffgehalt
EP0116628A4 (en) 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS AN ANI-HYPERTENSIVE.
DE3152363T1 (es)
DE3674997D1 (de) Holzbehandlungszusammensetzung.
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment